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The endocannabinoid (eCB) system is widely expressed in various parts of the central nervous system, including the retina. The
localization of the key eCB receptors, particularly CB1R and CB2R, has been recently reported in rodent and primate retinas with
striking interspecies differences. Little is known about the distribution of the enzymes involved in the synthesis and degradation
of these eCBs. We therefore examined the expression and localization of the main components of the eCB system in the retina of
mice, tree shrews, and monkeys. We found that CB1R and FAAH distributions are well-preserved among these species. However,
expression of NAPE-PLD is circumscribed to the photoreceptor layer only in monkeys. In contrast, CB2R expression is variable
across these species; in mice, CB2R is found in retinal neurons but not in glial cells; in tree shrews, CB2R is expressed in Mu¨ller
cell processes of the outer retina and in retinal neurons of the inner retina; in monkeys, CB2R is restricted to Mu¨ller cells. Finally,
the expression patterns of MAGL and DAGL𝛼 are differently expressed across species. Overall, these results provide evidence that
the eCB system is differently expressed in the retina of these mammals and suggest a distinctive role of eCBs in visual processing.
1. Introduction
Marijuana contains over 70 cannabinoids that mimic the
endogenous ligands called endocannabinoids (eCBs) that
cause global psychoactive and physiological effects. The eCB
system is mainly composed of the specific G-protein-coupled
receptors CB1R and CB2R, the eCBs (anandamide and
2-arachidonoylglycerol), the synthesising enzymes NAPE-
PLD (N-acyl phosphatidylethanolamine-specific phospholi-
pase D) and DAGL𝛼 (diacylglycerol lipase alpha), and the
degradation enzymes FAAH (fatty acid amide hydrolase) and
MAGL (monoacylglycerol lipase).The cannabinoid receptors
are found in many mammals and in various classes of
vertebrates and invertebrates and in all major subdivisions
of bilaterians, urochordates, and cephalochordates but not
in the nonchordate invertebrate phyla like insects [1–3]. The
cannabinoid receptors may have evolved in the last common
ancestor of the bilaterians with a secondary loss in the
insects and other clades [1]. The enzymes responsible for
the biosynthesis and the degradation of eCBs are present
throughout the animal kingdom [4, 5]. For example, in the
rat hippocampus, cerebellum, and amygdala, the distribution
of the cytosolic enzyme MAGL is complementary to FAAH
(presynaptic versus postsynaptic) suggesting different roles
for these two eCBs in the central nervous system (CNS)
[6]. The eCB system appears widely distributed in the CNS
and points to a fundamental modulatory role of eCBs in the
control of many central and peripheral biological functions
[7]. A number of specific roles have been ascribed to the
eCB system in biological functions, such as neuroprotection,
neurogenesis, axon guidance, synaptic plasticity, nociception,
motor activity, and memory [8–12]. Disturbances of normal
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eCB activity may therefore be associated with various brain
disorders [13–16].
The eCB system is also found in the retina of various
species [17] albeit noticeable differences in its anatomical
organization. Compared to rodents, the retina of tree shrews
is more similar to primates [18]. Mice have a rod-dominated
retina that is specialized for scotopic conditions [19] with
a low visual resolution [20]. Mouse and tree shrew retinas
have no fovea compared to primates. However, tree shrews
have a well-developed binocular visual system, with a cone-
dominated retina [21].
In the retina, the expression of CB1R is well-preserved in
many species including mice, rats, chicks, larval tiger sala-
manders, goldfish, and rhesusmonkeys [22]. CB1R andCB2R
are also present in various retinal cell types (cones, bipolar,
ganglion, horizontal, and amacrine cells) with however some
differences [17, 23–27]. For example, CB2R is expressed
throughout the mouse retina [25] but it is present exclusively
in the Mu¨ller cells of the vervet monkey [24]. In the mouse
retina, DAGL𝛼 andMAGL are widely distributed throughout
the IPL, whereas MAGL is present in rod spherules and cone
pedicles of the OPL [28]. BothMAGL and DAGL𝛼 have been
found in an overlapping pattern with CB1R and CB2R in the
rat retina. In rats, DAGL𝛼 is expressed from the early stages
of development in photoreceptors, horizontal, amacrine, and
ganglion cells and MAGL later during development mainly
in amacrine and Mu¨ller cells [29]. The expression and
distribution of the major components of the eCB system,
notably the metabolizing enzymes (NAPE-PLD, DAGL𝛼,
FAAH, and MAGL), in the retina of different mammals
have not been studied in depth. It is therefore our aim to
analyze the expression of several components of the eCB
system and to characterize their distribution pattern in the
distinct retinal layers and cell types of three different mam-
malian species: mice, tree shrews, and monkeys (vervets and
macaques).
2. Materials and Methods
2.1. Biological Material. Eyes from 3 adult mice (C57BL/6;
3-4 months old), 2 adult tree shrews (Tupaia belangeri; 3-
4 months old), 3 vervet monkeys (Chlorocebus sabaeus; 3-
4 years of age), and 2 rhesus monkeys (Macaca mulatta; 3-
4 years of age) were used in this study. The animals were
part of ongoing research projects that were approved by the
University of Montreal and McGill University Animal Care
and Use Committees. For all species, anterior segment of the
eye and vitreous were cut away. The eyecups were bathed
in 4% paraformaldehyde made in 0.1M sodium phosphate
buffer at pH 7.4 and left overnight in the solution. The retina
was dissected free from the eyecup in a phosphate-buffered
saline (PBS) medium. It was laid flat so that the vitreous
body could be removed by blotting with filter paper and
gentle brushing. Samples of the retinawere taken at the center
and periphery. Each sample was then cryoprotected in 30%
sucrose overnight and embedded in Shandon embedding
media at −65∘C. The blocks were cut in 20 𝜇m sections at
−18∘C with a Leica CM3050S cryostat and mounted onto
gelatinized subbed glass slides, air dried, and stored at −80∘C
for further processing.
2.2. Immunofluorescence. Single, double, and triple label-
ing of the retina were performed according to previously
published methods [23, 24, 30]. Briefly, the sections were
postfixed for 5 minutes in 70% ethanol, rinsed 3 × 5 minutes
in 0.1M Tris buffer and pH 7.4/0.03% Triton and blocked for
90 minutes in 10% normal donkey serum (NDS) in 0.1M
Tris buffer/0.5% Triton. Sections were then incubated with
primary antibodies prepared in blocking solution overnight
at room temperature. The cannabinoid-related antibodies
(CB1R, NAPE-PLD, FAAH, CB2R, DAGL𝛼, and MAGL)
were also used conjointly with a known specific retinal cell-
type marker (Table 1). The next day, sections were washed
for 10 minutes and 2 × 5 minutes in 0.1M Tris/0.03% Triton.
Then, they were blocked in 10% NDS and 0.1M Tris/0.5%
Triton for 60minutes and incubatedwith secondary antibody
for one hour (Alexa 488 donkey anti-mouse and biotinylated
donkey anti-rabbit followed by the addition of streptavidin-
Alexa 647 (1 : 200), all prepared in blocking solution). Sec-
tions were counterstained with Sytox Green Nucleic Acid
Stain (1 : 50,000;Molecular Probes, Inc., Eugene,OR), washed
again in Tris buffer, and coverslipped with Fluoromount-
GTM Mounting Medium (SouthernBiotech, Birmingham,
AL).
2.3. Antibody Characterization. In this study, we were con-
fronted with the problem concerning the specificity of some
of the antibodies, especially for the tree shrew. Although
knockout animals are the best way to test the specificity
of antibodies, this model is available only for mice and
not for tree shrews and monkeys. We therefore resorted to
the use of conventional alternative methods to circumvent
this methodological limitation [23–27]. We have previously
published Western blot results for mice and vervet monkeys
[23–25]. For tree shrews and macaques, the tissue was not
made available to us.Therefore, we resorted to the traditional
blocking techniques presented in the paper as BP in Figures
1 and 2. Table 1 summarizes the source and the working
dilution of all the primary antibodies. The antibodies used
in the present study were characterized and published in
previous publications: calbindin [23, 31–35], CB1R [23, 26],
CB2R [24, 36], DAGL𝛼 [26], FAAH [23, 27], GS [23, 37–
39], MAGL, NAPE-PLD [40], rhodopsin [30, 41], and PKC𝛼
[23, 26, 27, 34].
2.4. Confocal Microscopy. Immunofluorescence images were
taken according to [30]. Using a Leica TCS SP2 confocal
laser-scanning microscope (Leica Microsystems, Exton, PA),
with a 40x (n.a.: 1.25) or a 100x (n.a: 1.40–0.7) objective,
images were obtained sequentially from the green, blue,
or far-red channels on optical slices of less than 0.9𝜇m
of thickness. All photomicrograph adjustments, including
size, color, brightness, and contrast, were done with Adobe
Photoshop (CS5, Adobe Systems, San Jose, CA) and then
exported to Adobe InDesign (CS5, Adobe Systems, San Jose,
CA), where the final figure layout was completed.
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Table 1: List of antibodies used in this study.
Antibody1 Immunogen Source2 Working dilution
CB Purified bovine kidney calbindin-D28K Sigma-Aldrich, St. Louis, MO; C9848,mouse monoclonal, clone CB0955 1 : 250
CB1R Fusion protein containing aa 1–77 of ratCB1R
Calbiochem, Gibbstown, NJ; 209550,
rabbit polyclonal 1 : 150
CB2R Synthetic peptide corresponding to aa20–33 of human CB2R
Cayman Chemical, Ann Arbour, MI;
101550, rabbit polyclonal 1 : 150
DAGL𝛼
Peptide with sequence
CPAKQDELVISAR, from the C Terminus
of the protein sequence
Novus, Littleton, CO;
NBP2-31856, rabbit polyclonal 1 : 100
FAAH Synthetic peptide aa 561–579 of rat FAAH Cayman Chemical, Ann Arbour, MI;101600, rabbit polyclonal 1 : 150
GS Full protein purified from sheep brain Chemicon, Temecula, CA; MAB302,mouse monoclonal, clone GS-6 1 : 500
MAGL Human MAGL aa 1–14 Cayman Chemical, Ann Arbour, MI;100035, rabbit polyclonal 1 : 150
NAPE-PLD Purified protein corresponding to aa159–172 NAPE-PLD human
Cayman Chemical, Ann Arbour, MI;
10305, rabbit polyclonal 1 : 200
Rhodopsin Bovine rhodopsin Abcam, Toronto, ON; ab98887, mousemonoclonal, clone Rho 4D2 1 : 500
PKC𝛼 Peptide mapping the aa 296–317 ofhuman PKC𝛼
Santa Cruz Biotechnology, Santa Cruz,
CA; sc-8393, mouse monoclonal,
clone H-7
1 : 500
1CB: calbindin; CB1R: cannabinoid receptor type 1; CB2R: cannabinoid receptor type 2; DAGL𝛼: diacylglycerol lipase alpha; FAAH: fatty acid amide hydrolase;
GS: glutamine synthetase; MAGL: monoacylglycerol lipase; NAPE-PLD:N-acyl phosphatidylethanolamine-specific phospholipase D; PKC𝛼: protein kinase C
𝛼 (alpha isoform); aa: amino acids.
2The source column indicates the commercial company, catalog reference, and origin. The clone designation is given for monoclonal antibodies.
3. Results
3.1. Single-Label Immunofluorescence
3.1.1. CB1R Is Present Throughout the Retina of All Three
Species. A fairly consistent retinal distribution pattern of
CB1R across all six retinal layers was observed in mice,
tree shrews, vervet, and rhesus monkeys, as illustrated in
immunolabeled retinal sections (Figures 1(a)–1(d)).Themost
significant difference between species is the low expression of
CB1R in the ONL of mice when compared to all other species
(arrows, Figures 1(a)–1(d)). Furthermore, high expression of
CB1R is seen in the GCL and NFL of all species (arrowheads,
Figures 1(a)–1(d)).
3.1.2. FAAH Expression Is Found Throughout the Retina
of All Three Species. FAAH, like CB1R, is well expressed
in all retinal layers and in the photoreceptor layer of all
species (Figures 1(e)–1(h)). In all species, there is a moderate
protein expression in the INL (arrows, Figures 1(e)–1(h)).
Remarkably, there is an important expression of FAAH in the
NFL of all species (arrowheads, Figures 1(e)–1(h)).
3.1.3. NAPE-PLD Distribution Is Dissimilar between the
Species. Inmice,NAPE-PLD iswidely distributed in all layers
but more intensely in the NFL (arrowhead, Figure 1(i)). In
tree shrews, NAPE-PLD is found in all six retinal layers,
moderately in the INL (arrow, Figure 1(j)) and prominently
in the OPL and NFL (arrowheads, Figure 1(j)). Inversely, in
both vervet and macaque monkeys, NAPE-PLD is located in
the outer retina, mainly in photoreceptors, ONL and OPL
(arrowheads in Figures 1(k) and 1(l)), whilst it is undetectable
in the inner retinal layers (asterisks, Figures 1(k) and 1(l)).
3.1.4. CB2R Is Differently Expressed among the Species. Unlike
CB1R, the immunolabeling pattern of CB2R is not consistent
in the 3 species. In mice, CB2R is moderately detectable in
ONL and in INL (arrows Figure 2(a)) but strongly expressed
inOPL, IPL, GCL, andNFL (arrowheads, Figure 2(a)). In tree
shrews, CB2R is expressed throughout all retinal cell layers
with more emphasis (contrary to the mouse) in the external
layers (ONL) (upper arrowhead, Figure 2(b)) andNFL (lower
arrowhead, Figure 2(b)). In both vervets and macaques,
CB2R expression is more abundant in ONL (arrowheads,
Figures 2(c) and 2(d)) and is very low in the lower layers (INL,
IPL, GCL, and NFL) (asterisks, Figures 2(c) and 2(d)).
3.1.5. Localization of MAGL. In mice, MAGL is expressed in
the ONL, OPL, INL, IPL, GCL, and NFL (Figure 2(e)). The
most prominent staining is observed in the OPL, in the two
laminae of the IPL and in the NFL, as previously described
[28] (arrowheads, Figure 2(e)). In tree shrews, MAGL is
expressed in all layers and most strongly in the INL and GCL
(arrowheads, Figure 2(f)). In vervets andmacaques,MAGL is
expressed mainly in the OPL (arrowheads, Figures 2(g) and
2(h)). It is also foundmoderately in the IPL andGCL (arrows,
Figures 2(g) and 2(h)).
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Figure 1: CB1R system immunoreactivity pattern in the retina. Shown are retinal sections immunolabeled for CB1R ((a)–(d)), FAAH ((e)–
(h)), and NAPE-PLD ((i)–(l)) in mice, tree shrews, vervet, and macaque monkeys. The control staining, antibody preabsorption with the
corresponding blocking peptide (BP), is also shown for FAAH and NAPE-PLD in all species. Arrows point to low to moderate expression
of CB1R, FAAH, and NAPE-PLD in the retina of all species and arrowheads to high expression of these proteins. The asterisks indicate
undetectable expression of NAPE-PLD in the inner retina of monkeys. ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner
nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell layer; NFL: nerve fiber layer. Scale bar = 75 𝜇m.
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Figure 2: CB2R system immunoreactivity pattern in the retina. Shown are retinal sections immunolabeled for CB2R ((a)–(d)), MAGL
((e)–(h)), and DAGL𝛼 ((i)–(l)) in mice, tree shrews, vervet, and macaque monkeys. The control staining, antibody preabsorption with the
corresponding blocking peptide (BP), is also shown for CB2R,MAGL, and DAGL𝛼 in all species. Arrows point to low tomoderate expression
of CB2R, MAGL, and DAGL𝛼 in the retina all species and arrowheads to their high expression. The asterisks indicate expression of CB2R
under the detection level in the inner retina of monkeys. ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL:
inner plexiform layer; GCL: ganglion cell layer; NFL: nerve fiber layer. Scale bar = 75𝜇m.
3.1.6. Expression of the DAGL𝛼. In mice, DAGL𝛼 is weakly
expressed in the INL, moderately in OPL and ONL (arrows,
Figure 2(i)) but more strongly in the IPL (arrowhead,
Figure 2(i)). This result is consistent with that obtained in
the mouse retina [28] and in the rat retina [29] that showed
expression in the two synaptic layers, the OPL and IPL.
DAGL𝛼 is also highly expressed in the GCL and NFL in
the mouse retina (Figure 2(i)). In tree shrews, the DAGL𝛼
is strongly expressed in the GCL and NFL (arrowheads,
Figure 2(j)). In vervets and macaques, DAGL𝛼 is moderately
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Figure 3: CB1R immunoreactivity in rod bipolar cells. Vertical sections taken from themouse retina (first column), tree shrew retina (second
column), vervet retina (third column), and macaque retina (fourth column). Confocal micrographs of coimmunolabeling for CB1R and the
cell-type-specific marker for rod bipolar cells, protein kinase C alpha (PKC𝛼). Each protein expression is presented alone in grayscale: CB1R
in the first line and PKC𝛼 in the second line; then the two are presented merged (third line: CB1R in magenta and PKC𝛼 in green). Arrows
point to dendrites ascending into the OPL, where rod spherules are found, and arrowheads point to synaptic terminals in the IPL. INL: inner
nuclear layer; IPL: inner plexiform layer. Scale bar = 30 𝜇m.
expressed in the OPL (arrows, Figures 2(k) and 2(l)), whilst
there is a high expression in the NFL (arrowheads, Figures
2(k) and 2(l)).
3.2. Double-Label Immunofluorescence. To verify the retinal
cell-type expression, double immunostaining was carried out
with each eCB component and a specific molecular marker
for retinal cells.
3.2.1. CB1R and Rod Bipolar Cells. PKC𝛼 that labels rod
bipolar cells and a subset of amacrine cells is similarly
coexpressed with CB1R in the dendrites extending to theOPL
(arrows, Figure 3) and synaptic terminals in the IPL in all
species (arrowheads, Figure 3). This is in accordance with
previous data reported in rats [26] and vervet monkeys [23]
by our group.
3.2.2. CB2R andMu¨ller Cells. To labelMu¨ller cells, glutamine
synthetase (GS) was used. This antibody has proved to be
efficient to label Mu¨ller cells in the rat [38], mouse [25],
and monkey retinas [23, 24, 39]. In mice, CB2R is weakly
expressed in the ONL (Figures 4(a), 4(e), and 4(i)) although
intense expression was found in the inner layers. CB2R was
not found in Mu¨ller cells in the mouse retina as previously
reported [25]. In tree shrews, CB2R and GS were both
expressed in the photoreceptor layer andONL (arrow, Figures
4(b), 4(f), and 4(j)). Overall, CB2R is colocalized with GS in
the outer retina but not in the inner retina (Figure 4(j)). In
both vervet and macaque monkeys, double labeling of CB2R
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Figure 4: CB2R immunoreactivity inMu¨ller cells. Vertical sections from the mouse retina (first column), tree shrew retina (second column),
vervet retina (third column), and macaque retina (fourth column). Confocal micrographs of coimmunolabeling for CB2R and the cell-type-
specificmarker for glialMu¨ller cells, glutamine synthetase (GS). Each protein immunofluorescent signal is presented alone in grayscale: CB2R
in the first line and GS in the second line; then the two are presented merged (third line: CB2R in magenta and GS in green). Arrowheads
point toMu¨ller cell processes that all express CB2R, except inmice (arrows). ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner
nuclear layer; IPL: inner plexiform layer. Scale bar = 30 𝜇m.
andGS shows that CB2R is restricted toMu¨ller cell processes,
extending from the internal limiting membrane, with very
low staining, to the external limiting membrane, with heavy
labeling (arrowheads, Figures 4(c), 4(g), 4(k), 4(d), 4(h), and
4(l)). These results indicate that the expression of CB2R in
Mu¨ller cells is a feature of tree shrews and monkeys.
3.2.3. NAPE-PLD and Calbindin-Positive Retinal Cells. Cal-
bindin (CB) is a marker of cones outside the foveal region,
cone bipolar cells, and a subset of horizontal cells in tree
shrews and monkeys [23, 32]. On the contrary, in mice,
CB is a marker of horizontal cells and is present in OPL
with a weak colocalization of NAPE-PLD (Figures 5(a), 5(e),
and 5(i)). In both mice and tree shrews CB-positive cell
bodies found in the INL do not express NAPE-PLD (arrows,
Figures 5(a), 5(e), 5(i), 5(b), 5(f), and 5(j)). In fact, CB is
coexpressed with NAPE-PLD in the OPL of tree shrews
(arrowheads, Figures 5(b), 5(f), and 5(j)). CB is expressed in
theONL of themonkey retina where NAPE-PLD is abundant
(arrowheads, Figures 5(c), 5(g), 5(k), 5(d), 5(h), and 5(l)) and
highly coexpressed with NAPE-PLD in the axons of cone
photoreceptors (arrowheads, Figures 5(c), 5(g), 5(k), 5(d),
5(h), and 5(l)).
3.2.4. NAPE-PLD and Rods. The rhodopsin antibody was
used to label rods in the retina. In the mouse, NAPE-PLD
is not coexpressed with rods (arrows, Figures 6(a), 6(e),
and 6(i)). Furthermore, in the cone-dominant retina of the
8 Neural Plasticity
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Figure 5: NAPE-PLD immunoreactivity in calbindin-positive retinal cells. Vertical sections from the mouse retina (first column), tree shrew
retina (second column), vervet retina (third column), and macaque retina (fourth column). Confocal micrographs of coimmunolabeling for
the synthesizing enzyme NAPE-PLD and a cell-type-specific marker for horizontal cells or cones; in mice and tree shrews, calbindin (CB)
labels horizontal cells; in monkeys, CB labels cones. Each protein expression is presented alone in grayscale: NAPE-PLD in the first line and
the CB in the second line; then the two are presented merged (third line: NAPE-PLD in magenta and the CB in green). Arrowheads point to
the processes of CB-positive cells that express the synthetizing enzyme NAPE-PLD and arrows point to CB-positive cells bodies, which do
not express NAPE-PLD. ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer. Scale bar
= 30 𝜇m.
tree shrew with only very few rods, NAPE-PLD is also not
colocalized with rods (arrows, Figures 6(b), 6(f), and 6(j)).
However, in vervet and macaque monkeys, NAPE-PLD is
expressed in rods (arrowheads, Figures 6(c), 6(g), 6(k), 6(d),
6(h), and 6(l)).
4. Discussion
In this study, we compared the localization of 2 cannabinoid
receptors (CB1R andCB2R), 2 endocannabinoid synthesizing
enzymes (NAPE-PLD and DAGL𝛼), and 2 endocannabinoid
degrading enzymes (FAAH and MAGL) in the retina of
mice, tree shrews, and monkeys. This is the first study that
shows the expression pattern of all the above-mentioned eCB
components in the tree shrew retina as well as the localization
of the NAPE-PLD, MAGL, and DAGL𝛼 in the monkey
retina (Figure 7). These phylogenetically related species were
chosen due to the specialization of their visual systems: from
the primitive monocular, rod-dominated visual system in
mice with a low visual resolution to the well-developed visual
system in monkeys [42] that is similar to humans [43]. Tree
shrews are a species with binocular cone-dominated vision
that is phylogenetically between mice and monkeys [21, 44].
4.1. The Cannabinoid Receptors: Localization versus Function.
We recently reported that the distribution of the CB2R in the
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Figure 6: NAPE-PLD immunoreactivity in rod photoreceptors. Vertical sections from the mouse retina (first column), tree shrew retina
(second column), vervet retina (third column), and macaque retina (fourth column). Confocal micrographs of coimmunolabeling for the
synthesizing enzyme NAPE-PLD and the cell-type-specific marker for rods, rhodopsin. Each immunofluorescent signal is presented alone in
grayscale: NAPE-PLD in the first line and rhodopsin in the second line; then the two are presentedmerged (third line: NAPE-PLD inmagenta
and rhodopsin in green). Arrowheads point to rhodopsin-positive cell bodies that express NAPE-PLD in vervet and macaque monkeys only,
and arrows mark the lack of colocalization. ONL: outer nuclear layer. Scale bar = 30 𝜇m.
primate retina [24] is different than the rodent retina [25].
While the CB2R is expressed in the rodent retinal neuronal
cells [25], it is only expressed in the primate retinal glia,
the Mu¨ller cells [24]. This finding prompted us to look into
the retinal eCB system expression profiles across species.
Interestingly, we show that only some components of the eCB
system are preserved across the three animal species studied
here while others are strikingly different. Notably, as reported
by Elphick in his thought-provoking review [5], CB1R and
CB2R are unique to chordates, but the enzymes involved in
the biosynthesis and the inactivation of the eCBs like NAPE-
PLD and FAAH are found throughout the animal kingdom
[4].These proteins may have therefore evolved as presynaptic
or postsynaptic receptors for eCBs.This is fascinating because
the expression and localization ofCB1R andFAAHare similar
in mice, tree shrews, and primates, while it is not the case for
CB2R, NAPE-PLD, MAGL, and DAGL𝛼 (Figure 7).
There are many controversies on the neuronal and/or
peripheral expression of CB2R. Our results show that the
expression pattern of the CB2R differs from the mouse to the
monkey. Similar to CB1R, CB2R shows a general expression
in the neuroretina: photoreceptors, horizontal cells, amacrine
cells, and cells localized in the GCL of rodents [25, 45]. In
the mouse, CB2R, expressed in the photoreceptor layer, was
mostly found in cones and some rods [25]. Similar to its
position in the phylogeny tree, the tree shrew has an in-
between position showing expressions in all layers, as in
rodents, and in Mu¨ller cells, as in primates (Figure 2(b)). In
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Figure 7: Comparison of the expression patterns of the CB1 system components CB1R, FAAH, and NAPE-PLD (a) and of the CB2 system
components CB2R, MAGL, and DAGL𝛼 (b) in the retina of mice, tree shrews, vervets, and macaques. Our results are complemented by data
from previously published work [23, 26, 28, 29].
agreement with the CB2R glial expression in the CNS, the
primate retina expresses CB2R mainly in Mu¨ller cells, with a
higher polarization towards the outer retina [24]. TheMu¨ller
cells, with their unique anatomy, span the entire thickness
of the retina and contact with the majority of the retinal
neurons [46]. This complementary expression pattern of
CB1R andCB2R in the primate retina reveals thus a reciprocal
relationship between retinal neurons and glia regarding their
function via the eCB system. The ubiquitous CB1R system
may play a more general role in the light transduction in all
three species, as previously suggested [17].
4.2. Significance of the Distribution Pattern of Enzymes and
Cannabinoid Receptors. The expression pattern of CB1R and
FAAH has been reported in the CNS as complementary,
overlapping, or unrelated distributions [17, 47]. Here, we
report an overlapping distribution; CB1R expressing neurons
also express FAAH. In this case, the degrading enzyme may
remotely influence the CB1R [47]. During development of
the mouse retina, CB1R and FAAH expression patterns are
present in the deepest neuroblast layers at birth and spread
out throughout the retina in adulthood [26, 27]. In our three
species, the FAAH expression overlaps the CB1R distribution
pattern not only in the photoreceptor layers but also in the
ganglion cells (Figures 1(a)–1(d) and 1(i)–1(l)). This suggests
that cannabinoids act not only on photoreceptors [17] but
also directly on ganglion cell. This expression pattern has
been reported not only in the retina of the vervet monkey
[23] but also in the optic nerve, the dorsal lateral geniculate
nucleus [40], and the visual cortex of monkeys [48]. While
NAPE-PLD and FAAH are overlapping in different layers of
the mouse and tree shrew retinas, they are complementarily
expressed in the monkey retina. This unique complementary
spatial relationship between NAPE-PLD (exclusively in the
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photoreceptor layer) and FAAH (in the inner retina) might
ensure optimal retinal function in highly developed retinas.
However, further experiments are needed to test this hypoth-
esis.
Anandamide (an endogenous agonist of the CB1R) and
other N-acylethanolamines (NAEs) are biosynthesized from
phospholipids of the cell membrane assisted by NAPE-
PLD hydrolysis. In this study, we report a variation in the
expression of this membrane associated synthesis enzyme,
NAPE-PLD, despite its well-preserved sequence from rodents
to humans [49]. In the mouse, NAPE-PLD follows the same
pattern of expression as CB1R and FAAH, except that it is
not found in rods. Moreover, unlike the mouse but like the
primate, the tree shrew has a high expression of NAPE-
PLD in ONL and OPL. We show here for the first time that
NAPE-PLD expression inmonkeys is exclusively restricted to
the photoreceptor layer. Unlike CB1R, NAPE-PLD is ubiqui-
tously expressed in the rat brain with the highest level in the
thalamus [50]. Besides its role in the eCB biosynthesis, many
other physiological roles have been linked to NAPE-PLD
such as anti-inflammatory effect [51], anorexic effect [52],
and proapoptotic effect [53]. Moreover, the NAE products
in axons suggest a role in the regulation of postsynaptic
neuron activity as anterograde synaptic signaling molecules
[54]. This pattern of expression also suggests another direct
role of NAEs in primate phototransduction.
Given that the lipophilic eCBs are released and degraded
close to their action site, it would be reasonable to assume
that the DAGL𝛼 and MAGL expressions are in the vicinity
of CB2R. In the mouse retina, the DAGL𝛼 and MAGL
expressions are often near or in the same cell types as CB1R
and CB2R. CB1R is present in cones, horizontal, bipolar,
amacrine, and ganglion cells in the rat retina [26, 27]. CB2R is
present in cone and rod photoreceptors, horizontal, bipolar,
amacrine, and ganglion cells in the adult mouse retina [25].
This distribution pattern may suggest that, in the mouse
retina, eCBs such as 2-arachidonoyl glycerol are faithfully
expressed adjacent to the cannabinoid receptors and could be
involved in their retinal function [25]. But the primates and
the tree shrews have followed a complementary distribution
pattern, and may have adopted a more complex and specific
strategy to regulate their visual activity via the eCB system.
The eCB expression pattern in the mouse rod-dominated
retina withmonocular vision, the tree shrew cone-dominated
retina with binocular vision, and the monkey duplex retina
with binocular vision proposed that the retinal eCB system
plays a fundamental role in the mammal visual processing.
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